Equitec Proprietary Markets »

Pharmacyte Biotech shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2024-03-31 $196k 83k 2.37
2023-12-31 $179k 83k 2.16
2023-09-30 $174k 83k 2.10
2023-06-30 $176k 61k 2.86
2023-03-31 $962k 331k 2.91
2022-12-31 $969k 331k 2.93
2022-09-30 $794k 331k 2.40
2022-06-30 $768k 343k 2.24
2022-03-31 $711k 309k 2.30
2021-12-31 $647k 259k 2.50

More positions owned by Equitec Proprietary Markets

United States Steel Corporation Call Option (X)
Super Micro Computer Call Option (SMCI)
Applied Digital Corp Com New (APLD)
NVIDIA Corporation (NVDA)
B. Riley Financial (RILY)
Capri Holdings SHS (CPRI)
Microstrategy Cl A New (MSTR)
Fusion Pharmaceuticals Call Option (FUSN)
Amedisys (AMED)
Brookfield Infrastructure Com Sb Vtg Shs A (BIPC)
Vizio Hldg Corp Cl A Com (VZIO)
Angel Oak Finl Strategies In Com Ben Int (FINS)
Cannae Holdings (CNNE)
Doubledown Interactive Co Lt Ads (DDI)
American Equity Investment Life Holding (AEL)

View all positions for Equitec Proprietary Markets

Top funds holding Pharmacyte Biotech

K2 Principal Fund
Geode Capital Management
Vanguard Group
Equitec Proprietary Markets
Susquehanna International
Dimensional Fund Advisors
Schonfeld Strategic Advisors
BlackRock
Northern Trust
Citadel Advisors
Acadian Asset Management
Tower Research Capital
Advisor Group Holdings
CWM
Aspire Private Capital

View all funds holding Pharmacyte Biotech